1. Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004; 93:88-96.
2. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999;162:1930-33.
3. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urol-ogy. 2000;56:58-62.
4. Soong M, Jupiter J, Rosenthal D. Radiofrequency abla-tion of osteoid osteoma in the upper extremity. Hand Surg [Am]. 2006;31:279-283.
5. Susini T, Nori J, Olivieri S, et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol On-col. 2007;104:304-310. Epub 2006 Oct 27.
6. Amersi FF, McElrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unre-sectable liver tumors. Arch Surg. 2006;141:581-588.
7. Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC, Schulman CC. Radiofrequency in-terstitial tumor ablation (RITA) is a possible new modal-ity for treatment of renal cancer: ex vivo and in vivo ex-perience. J Endourol 1997; 11:251-258.
8. Rehman J, Landman J, Lee D, Venkatesh R, Bostwick DG, Sundaram C, Clayman RV. Needle-based ablation of re-nal parenchyma using microwave, cryoablation, imped-ance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: la-boratory studies and review of the literature. J En-dourol 2004; 18:83-104.
9. Matsumoto ED, Johnson DB, Ogan K, et al. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology. 2005;65:877-881.
10. Margulis V, Matsumoto ED, Lindberg G, et al. Acute histologic effects of temperaturebased radiofrequency ablation on renal tumor pathologic interpretation. Urology.2004;64:660-663.
11. Matsumoto ED, Watumull L, Johnson DB, et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol. 2004;172:45-48.
12. Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology. 2005;235:1065-1071.
13. Wen CC, Nakada SY. Energy ablative techniques for treatment of small renal tumors. Curr Opin Urol 2006; 16:321-326.
14. Kunkle D EB, Uzzo R. Excise, ablate or observe: the small renal mass dilemma- a metaanalysis and review. J Urol 2008; 179.
15. Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007; 100:287-290.
16. Turna B, Kaouk JH, Frota R, Stein RJ, Kamoi K, Gill IS, Novick AC. Minimally invasive nephron sparing man-agement for renal tumors in solitary kidneys. J Urol 2009; 182:2150-2157.
17. Salas N, Ramanathan R, Dummett S, Leveillee RJ. Re-sults of radiofrequency kidney tumorablation: renal function preservation and oncologic efficacy. World J Urol 2010.
Thank you for copying data from http://www.arastirmax.com
